Go to menu Go to main text

Medical Service

Heart

Why Heart in Korea

  • 01 World-Class Treatment of Ischemic Heart Disease
    • Ischemic heart disease mortalities in Korea stand at 35 people per 100,000 population, extremely lower than the OECD average(115 people per 100,000 population).
    • Mortality in Korea related to ischemic heart disease has been decreasing rapidly since 1990.
      • The mortality rate due to ischemic heart disease in Korea has decreased 24% on average every year since 1990, thanks to the development of a revolutionary treatment.
    • Factors in the development of cardiac infarction treatment.
      • The introduction of CCU (Coronary Care Unit)
      • The advancements in CABG (Coronary Artery Bypass Grafting) and PCI (Percutaneous Coronary Intervention)
      • The development of state-of-the-art medical equipment and coronary stents
  • 02 Korea, The Country that Saves Lives
    • Korea achieved its first successful artificial cardiopulmonary bypass surgery in 1959 through the Minnesota project.
      • South Korean doctors save the lives of foreign patients in Korea, and teach and train overseas doctors
    • From 1984 to late 1990s: With the establishment of the Korea Heart Foundation, Korea’s cardiac surgery technologies strived to develop surgical solutions for congenital heart defects.
    • 2000s: Surgeries on acquired heart diseases such as coronary artery diseases or valvular diseases increased significantly.
    • Now, Korea has gained world wide reputation for advanced cardiac surgery technologies and skills.
  • 03 No.1 Heart Transplant Success Rate in the World
    • In 1992, the first successful heart transplant in Korea.
    • In 2005, success in transplanting hearts and kidneys simultaneously.
    • Survival rate of cardiac surgery is 96.2% for short term and the 4-year survival rate is 84% ; figures that are higher than those of any other country in the world.
    • In 1997, the first successful heart transplant for an infant having 0% of the early recorded mortality rate.
    Source
    2018 KOTRY annual report
    Korea’s Heart Transplant Status, Unit : case
    Korea’s Heart Transplant Status, Unit : case : Total,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023
    Total 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
    2,521 19 98 107 127 118 145 156 184 176 194 173 168 167 245
    Source
    KODA(Korea Organ Donation Agency)
  • 04 1-2days Minimal Hospitalization for Percutaneous Coronary Intervention (PCI)
    • Thanks to advances in coronary intervention techniques and the development of a variety of stents, Korea's post PCI in hospital all-cause mortality was just 2.4%. And cardiac cause was 1.8% (source : K-PCI registry).
    • The mortality rate of myocardial infarction patients in Korea is 5.2%. And the mortality rate at 12months after discharge in patients with AMI in Korea was 0.4%.
    • The incidence of MACE (Major Adverse Cardiac Events) in Korea is 2.4~3.5%.
    Source
    KRAMI 2019
  • 05 Reduced Mortality Rate Through Surgery and Interventional Procedures in Congenital Heart Defects
    • Korea is reducing the mortality and hospitalization period by applying surgical and interventional treatment, 1.1% of the mortality rate of patients.
    Mortality rate of congenital heart defect treatment in Korea
    Mortality rate of congenital heart defect treatment in Korea : year,Case,Death,Mortality
    year Case Death Mortality
    2014 5,646 93 1.60%
    2015 5,802 84 1.50%
    2016 5,723 105 1.90%
    2017 5,448 82 1.70%
    2018 4,859 54 1.10%
    2019 5,567 61 1.10%
    Source
    Mortality rate of congenital heart defect treatment in Korea
  • 06 Establishment and Operation of 11 Designed Cardiac and Cerebral Vascular Disease Centers by The Government
    • Korean government established a plan for the 'Institution and Operation of Cardiac and Cerebral Vascular Disease Centers' in 2008.
    • 95% of the patients takes less than 90 minutes, between arriving to an emergency room to receiving primary coronary angiography (source: KRAMI 2019).
    • Cardio-Cerebrovascular disease centers have been in operation in 11 districts across the country (24-hour operation).
      Providing professional treatment services in a timely manner, including CP (Critical Pathway) develo- pment and distribution, and early rehabilitation.
    • Providing appropriate medical treatment to cardiovascular disease patients in the initial stage in timely manner so as to increase the treatment performance
    Source
    KRAMI 2019
  • 07 Korea Achieved Success in Open Heart Surgery for Extremely Low Birth Weight Infants
    • Open heart surgery can be applicable to most congenital heart defect patients which enables to lead a normal life.
    • Open heart surgery is a surgical method to treat the heart by opening the chest. Although this is difficult to perform on premature babies weighing under 1,200g, Korea has achieved numerous surgical successes on infants with extremely low weight.
    Annual Number of Congenital Cardiac Surgery Cases and Mortality Rates in Korea
    Annual Number of Congenital Cardiac Surgery Cases and Mortality Rates in Korea : year,Case,Death,Mortality
    year Case Death Mortality
    2014 3,625 93 2.60%
    2015 3,349 84 2.50%
    2016 3,335 105 3.10%
    2017 3,149 82 2.60%
    2018 2,788 59 2.10%
    2019 2,988 61 2.00%
    Source
    Korea Heart Foundation 2014~2019
  • 08 Valve Surgery With World-Leading Performance
    • Transcatheter Aortic Valve Implantation
      • Over 4,000 cases of valve surgery are performed at Korean medical institutions annually with a mortality rate of 2.5 to 3.7 % demonstrating Korea's excellence.
      • Valve treatment can be divided into surgical and percutaneous procedure.
        • The surgical method depends on the age of the patient, the associated diseases and the consent of the patient or guardian.
  • 09 Excellence of TAVI (Transcatheter Aortic Valve Implantation Procedure)
    • In Korea, the first TAVI procedure was performed in 2011, and now, TAVI procedures are actively performed in about 20 institutions, making Korea the leading country to perform TAVI procedures in Asia.
    • Korea’s current nationwide TAVI procedure results are summarized in the K-TAVI fact sheet 2017, and it states that the occurrence rate of cardiac deaths was 3.3% one year after procedure, and the occurrence rate of disabling stroke was 2.5% one year after procedure; the results were considered world-class.
    Source
    KRAMI 2019
  • 10 World’s Leading Coronary Artery Bypass Technologies
    • Korea features a relatively high level of OPCAB(Off-Pump CABG).
    • In addition to the stability and effectiveness of OPCAB, a number of studies are being performed on the opening of graft, on surgical techniques using a complete arterial catheter, on minimaly invasive surgical techniques, and on protecting the brain using techniques that involve no touching of the aorta.
    • Aboot 300 caces of coronary artery bypass are performed annually, and the mortality rate is only 2.6 to 3.9%.
    Annual Number of Coronary Artery bypass Surgeries and Mortality Rates in Korea
    Annual Number of Coronary Artery bypass Surgeries and Mortality Rates in Korea : year,Case,Death,Mortality
    year Case Death Mortality
    2014 2,862 78 2.70%
    2015 3,193 107 3.40%
    2016 2,990 79 2.60%
    2017 3,312 109 3.50%
    2018 3,381 112 3.30%
    2019 3,370 130 3.90%
    Source
    Korea Heart Foundation 2014~2019
  • 11 Korea’s Cardiovascular Intervention Skills Go Global
    • Diagnostic coronary angiography rarely causes surgical complications and generates a mortality rate of only 0.14 to 0.75%.
    • After diagnostic coronary angiography, coronary intervention is performed. The mortality rate of patients with acute myocardial infarction who receive this procedure is only 1.2 to 5.5% in Korea, which is similar to that of the United States (3.5%).
      • The rate of recurrence within 1 year is 2.5 to 9.5%, and the average hospitalization period is 3.0 to 9.5 days, closely matching statistics in the United States and European countries
    • Angina patients generally experience complicated lesions and stenosis in multiple areas due to the chronically developed disease.
      • The mortality rate, the rate of recurrence within 1 year and the hospitalization period in Korea are 0.1 to 1.4%, 2.4 to 6.0% and 1.7 to 4.0 days, respectively.
    • Even Korea's medical technologies to treat left main vessel diseases or chronic total occlusion, which used to be difficult to treat surgically, are setting the global standard. An increasing number of foreign physicians are visiting Korea to learn Korea's techniques every year.
    Source
    KRAMI 2019, KPCI 2019

Advanced Treatment

  • 01 Intervention Certificate System
    • The Korean society of interventional cardiology (KSIC) takes the lead in the intervention certification system for the quality management of institutions and interventional cardiologists. Currently, there are about 90 institutions and 400 interventional cardiologists in Korea who have been certified by KSIC for their practices.
  • 02 Pioneer of Left Main Coronary Artery Procedure
    • In Korea, even during the period when these procedures were prohibited in the guidelines, the intervention and stent procedure were introduced to treat the left main coronary artery lesion to lead the left main coronary artery intervention. For the current change and update in the guidelines that enable performing a stent procedure for the left main coronary artery lesion, the effort and experience of Korean interventional cardiologists made important contributions. While Korea is leading the left main coronary artery intervention, the expertise of each institution and interventional cardiologist has been accumulated and from which, safe and effective treatment is generally being laid out and performed for the left main coronary artery lesion.
  • 03 Leader of Cardiovascular Physiology
    • With the technology of evaluating cardiovascular physiology, a strategy of selectively inserting a stent into a lesion where significant ischemia is found has been actively accepted by Korea to lead the world’s medicine and procedural skills. These efforts by Korea made large contributions to charge various guidelines so that the ischemic degree must be objectively evaluated first before performing intervention.
  • 04 High Performance Rate of Radial Artery Approach Procedure
    • By comprehensively considering various parameters such as the status of the patient, location and form of the lesion, complexity of the procedure, degree of the emergency, etc, the appropriate route between the femoral artery and radial artery is determined for intervention. Recent studies report that a procedure using the radial artery can reduce complication occurrences and enable moving, in an short time so that the subjective satisfaction of the patient can be improved. Currently, in about 30% of cases in the United States, the radial arteries are used, but in 60% of cases in Korea, the radial arteries are used so that Korea’s interventional technology is leading the world.
Medical Korea